Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway

International Journal of Molecular Medicine

Volumn 35, Issue 5, 2015, Pages 1381-1387

  Dong, Fengyun ^a   Tian, Hu ^b   Yan, Suhua ^b   Li, Liqun ^a   Dong, Xiaofeng ^b   Wang, Fuhai ^b   Li, Jie ^b   Li, Changsheng ^a   Cao, Zhiqun ^c   Liu, Xiaochun ^d   Liu, Ju ^a  

^a SHANDONG UNIVERSITY   (China)

^b Department of General Surgery ^*  (China)

^c Jinan Hospital of Chinese Medicine   (China)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Angiogenesis; Dihydroartemisinin; Endothelial cell; Extracellular signal regulated kinase; Proliferation

Indexed keywords

DIHYDROARTEMISININ; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; PROTEIN C FOS; ARTEMISININ DERIVATIVE;

ANTIANGIOGENIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; DOSE RESPONSE; DRUG EFFECTS; EPITHELIUM CELL; METABOLISM; PHOSPHORYLATION;

ARTEMISININS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION;

EID: 84925391729     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2015     Document Type: Article

References (39)

1. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31, 1995.
2. Ferrara N, Gerber HP and Le Couter J: The biology of VEGF and its receptors. Nat Med 9:669-676, 2003.
3. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407:249-257, 2000.
4. Costa C, Soares R and Schmitt F Angiogenesis: now and then. APMIS 112:402-412, 2004
5. Klagsbrun M and Moses MA: Molecular angiogenesis. Chem Biol 6:R217-R224, 1999
6. Risau W: Mechanisms of angiogenesis. Nature 386:671-674, 1997
7. Liu J and Kapron CM: Differential induction of MAP kinase signalling pathways by cadmium in primary cultures of mouse embryo limb bud cells. Reprod Toxicol 29:286-291, 2010.
8. Page C and Doubell AF: Mitogen-activated protein kinase (MAPK) in cardiac tissues. Mol Cell Biochem 157:49-57, 1996.
9. Hoefen RJ and Berk BC: The role of MAP kinases in endothelial activation. Vascul Pharmacol 38:271-273, 2002.
10. Tu Y: The development of new antimalarial drugs: qinghaosu and dihydro-qinghaosu. Chin Med J (Engl) 112:976-977, 1999
11. Crespo-Ortiz MP and Wei MQ: Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug. J Biomed Biotechnol 2012:247597, 2012.
12. Chen HH, Zhou HJ, Wang WQ and Wu GD: Antimalarial dihydroartemisinin also inhibits angiogenesis. Cancer Chemother Pharmacol 53:423-432, 2004
13. Longo M, Zanoncelli S, Torre PD, et al: In vivo and in vitro investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos. Reprod Toxicol 22:797-810, 2006.
14. Chen HH, Zhou HJ and Fang X: Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro. Pharmacol Res 48:231-236, 2003.
15. Wu GD, Zhou HJ and Wu XH: Apoptosis of human umbilical vein endothelial cells induced by artesunate. Vascul Pharmacol 41:205-212, 2004
16. D'Alessandro S, Basilico N, Corbett Y, et al: Hypoxia modulates the effect of dihydroartemisinin on endothelial cells. Biochem Pharmacol 82:476-484, 2011.
17. Sarina, Yagi Y, Nakano O, et al: Induction of neurite outgrowth in PC12 cells by artemisinin through activation of ERK and p38 MAPK signaling pathways. Brain Res 1490:61-71, 2013.
18. Wang Y, Huang ZQ, Wang CQ, et al: Artemisinin inhibits extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinase-9 expression via a protein kinase C5/p38/extracellular signal-regulated kinase pathway in phorbol myristate acetate-induced THP-1 macrophages. Clin Exp Pharmacol Physiol 38:11-18, 2011.
19. Lu JJ, Meng LH, Cai YJ, et al: Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species. Cancer Biol Ther 7:1017-1023, 2008.
20. Guo L, Dong FY, Hou YL, et al: Dihydroartemisinin inhibits VEGF-induced endothelial cell migration by a p38 MAPK-independent pathway. Exp Ther Med 8:1707-1712, 2014
21. Carmeliet P and Jain RK: Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298-307, 2011.
22. Davis RJ: Transcriptional regulation by MAP kinases. Mol Reprod Dev 42:459-467, 1995
23. Monick MM, Geist LJ, Stinski MF and Hunninghake GW: The immediate early genes of human cytomegalovirus upregulate expression of the cellular genes myc and fos. Am J Respir Cell Mol Biol 7:251-256, 1992.
24. Dudley DT, Pang L, Decker SJ, Bridges AJ and Saltiel AR: A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92:7686-7689, 1995.
25. Hong J, Kandasamy K, Marimuthu M, Choi CS and Kim S: Electrical cell-substrate impedance sensing as a non-invasive tool for cancer cell study. Analyst 136:237-245, 2011.
26. Ferrara N and Kerbel RS: Angiogenesis as a therapeutic target. Nature 438:967-974, 2005.
27. Oh S, Jeong IH, Shin WS and Lee S: Growth inhibition activity of thioacetal artemisinin derivatives against human umbilical vein endothelial cells. Bioorg Med Chem Lett 13:3665-3668, 2003.
28. Feng D, Nagy JA, Pyne K, Hammel I, Dvorak HF and Dvorak AM: Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators. Microcirculation 6:23-44, 1999.
29. Boulton TG and Cobb MH: Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies. Cell Regul 2:357-371, 1991.
30. García F, Zalba G, Páez G, Encío I and De Miguel C: Molecular cloning and characterization of the human p44 mitogen-activated protein kinase gene. Genomics 50:69-78, 1998.
31. Owaki H, Makar R, Boulton TG, Cobb MH and Geppert TD: Extracellular signal-regulated kinases in T cells: characterization of human ERK1 and ERK2 cDNAs. Biochem Biophys Res Commun 182:1416-1422, 1992.
32. He Y, Fan J, Lin H, et al: The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1α in human rheumatoid arthritis fbroblast-like synoviocyte. Rheumatol Int 31:53-60, 2011.
33. Lee J, Zhou HJ and Wu XH: Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells. Cancer Chemother Pharmacol 57:213-220, 2006.
34. Yin D, Jia T, Gong W, et al: VEGF blockade decelerates the growth of a murine experimental osteosarcoma. Int J Oncol 33:253-259, 2008.
35. Kosaka C, Sasaguri T, Komiyama Y and Takahashi H: All-trans retinoic acid inhibits vascular smooth muscle cell proliferation targeting multiple genes for cyclins and cyclin-dependent kinases. Hypertens Res 24:579-588, 2001.
36. Lu JJ, Meng LH, Shankavaram UT, et al: Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells. Biochem Pharmacol 80:22-30, 2010.
37. Lovren F, Pan Y, Quan A, et al: Adropin is a novel regulator of endothelial function. Circulation 122(Suppl 11):S185-S192, 2010.
38. Alvarez G, Visitación Bartolomé M, Miana M, et al: The effects of adiponectin and leptin on human endothelial cell proliferation: a live-cell study. J Vasc Res 49:111-122, 2012.
39. Wang L, Chen Q, Li G and Ke D: Ghrelin stimulates angiogenesis via GHSR1a-dependent MEK/ERK and PI3K/Akt signal pathways in rat cardiac microvascular endothelial cells. Peptides 33:92-100, 2012.